Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein

ACS Chemical Biology

Volumn 3, Issue 12, 2008, Pages 765-775

  Zhou, Zhigang ^a,c   Khaliq, Mansoora ^b   Suk, Jae Eun ^a   Patkar, Chinmay ^b,d   Li, Long ^b   Kuhn, Richard J ^b   Post, Carol Beth ^a,b  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN E2; LIGAND; PEPTIDE LIBRARY; ANTIVIRUS AGENT; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANTIVIRAL THERAPY; ARTICLE; CELL ASSAY; DENGUE VIRUS; DRUG BINDING SITE; DRUG PROTEIN BINDING; DRUG SCREENING; HIGH THROUGHPUT SCREENING; MOLECULAR DOCKING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN DOMAIN; VIROGENESIS; VIRTUAL REALITY; VIRUS ENVELOPE; VIRUS INHIBITION; ANIMAL; BINDING SITE; CELL LINE; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER SIMULATION; DRUG ANTAGONISM; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HAMSTER; MOLECULAR LIBRARY; STRUCTURE ACTIVITY RELATION;

DENGUE VIRUS;

ANIMALS; ANTIVIRAL AGENTS; BINDING SITES; CELL LINE; CELL SURVIVAL; COMPUTER SIMULATION; CRICETINAE; DENGUE VIRUS; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR STRUCTURE; SMALL MOLECULE LIBRARIES; STRUCTURE-ACTIVITY RELATIONSHIP; VIRAL ENVELOPE PROTEINS;

EID: 58949091895     PISSN: 15548929     EISSN: None     Source Type: Journal    
DOI: 10.1021/cb800176t     Document Type: Article

References (27)

1. Lindenbach, B. D., and Rice, C. M. (2001) Flaviviridae: The viruses and their replication, in Fields Virology (Knipe, D., and Howley, P., Eds.), pp 991-1041, Lippincott Williams & Wilkins, Philadelphia.
2. Morens, D. M., and Fauci, A. S. (2008) Dengue and hemorrhagic fever: A potential threat to public health in the United States, JAMA, J. Am. Med. Assoc. 299, 214-216.
3. Zhang, Y., Corver, J., Chipman, P. R., Zhang, W., Pletnev, S. V., Sedlak, D., Baker, T. S., Strauss, J. H., Kuhn, R. J., and Rossmann, M. G. (2003) Structures of immature flavivirus particles, EMBO J. 22, 2604-2613.
4. Kuhn, R. J., Zhang, W., Rossmann, M. G., Pletnev, S. V., Corver, J., Lenches, E., Jones, C. T., Mukhopadhyay, S., Chipman, P. R., Strauss, E. G., Baker, T. S., and Strauss, J. H. (2002) Structure of dengue virus: Implications for flavivirus organization, maturation, and fusion. Cell 108, 717-725.
5. Zhang, Y., Zhang, W., Ogata, S., Clements, D., Strauss, J. H., Baker, T. S., Kuhn, R. J., and Rossmann, M. G. (2004) Conformational changes of the flavivirus E glycoprotein, Structure 12, 1607-1618.
6. Modis, Y., Ogata, S., Clements, D., and Harrison, S. C. (2004) Structure of the dengue virus envelope protein after membrane fusion. Nature (London, U.K.) 427, 313-319.
7. Modis, Y., Ogata, S., Clements, D., and Harrison, S. C. (2003) A ligand-binding pocket in the dengue virus envelope glycoprotein, Proc. Natl. Acad. Sci. U.S.A. 100, 6986-6991.
8. Zhang, W., Chipman, P. R., Corver, J., Johnson, P. R., Zhang, Y., Mukhopadhyay, S., Baker, T. S., Strauss, J. H., Rossmann, M. G., and Kuhn, R. J. (2003) Visualization of membrane protein domains by cryo-electron microscopy of dengue virus, Nat. Struct. Biol. 10, 907-912.
9. Modis, Y., Ogata, S., Clements, D., and Harrison, S. C. (2005) Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein, J. Virol. 79, 1223-1231.
10. Rey, F. A., Xeinz, F. X., Mandl, C., Kunz, C., and Harrison, S. C. (1995) The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution, Nature (London, U.K.) 375, 291-298.
11. Diana, G. D., McKinlay, M. A., Otto, M. J., Akullian, V., and Oglesby, C. (1985) (4,5-Dihydro-2-oxazolyl)phenoxy alkyl isoxazoles. Inhibitors of picornavirus uncoating, J. Med. Chem. 28, 1906-1910.
12. Goncalves, R. B., Mendes, Y. S., Soares, M. R., Katpally, U., Smith, T. J., Silva, J. L., and Oliveira, A. C. (2007) VP4 protein from human rhinovirus 14 is released by pressure and locked in the capsid by the antiviral compound WIN, J. Mol. Biol. 366, 295-306.
13. Hadfield, A. T., Oliveira, M. A., Kim, K. H., Minor, I., Kremer, M., Heinz, B. A., Shepard, D., Pevear, D. C., Rueckert, R. R., and Rossmann, M. G. (1995) Structural studies on human rhinovirus 14 drug-resistant compensation mutants, J. Mol. Biol. 253, 61-73.
14. Zhang, Y., Simpson, A. A., Ledford, R. M., Bator, C. M., Chakravarty, S., Skochko, G. A., Demenczuk, T. M., Watanyar, A., Pevear, D. C., and Rossmann, M. G. (2004) Structural and virological studies of the stages of virus replication that are affected by antirhinovirus compounds, J. Virol. 78, 11061-11069.
15. Szymkowski, D. E. (2005) Creating the next generation of protein therapeutics through rational drug design, Curr. Opin. Drug Discovery Dev. 8, 590-600.
16. Vajda, S., and Guarnieri, F. (2006) Characterization of protein-ligand interaction sites using experimental and computational methods, Curr. Opin. Drug Discovery Dev. 9, 354-362.
17. Zhou, Z., Madrid, M., Evanseck, J. D., and Madura, J. D. (2005) Effect of a bound non-nucleoside RT inhibitor on the dynamics of wild-type and mutant HIV-1 reverse transcriptase, J. Am. Chem. Soc. 127, 17253-17260.
18. Zhou, Z., and Madura, J. D. (2004) Relative free energy of binding and binding mode calculations of HIV-1 RT inhibitors based on dock-MM-PB/GS, Proteins: Struct., Funct., Bioinf. 57, 493-503.
19. Li, Y., Zhou, Z., and Post, C. B. (2005) Dissociation of an antiviral compound from the internal pocket of human rhinovirus 14 capsid, Proc. Natl. Acad. Sci. U.S.A. 102, 7529-7534.
20. Phelps, D. K., and Post, C. B. (1999) Molecular dynamics investigation of the effect of an antiviral compound on human rhinovirus, Protein Sci. 8, 2281-2289.
21. Speelman, B., Brooks, B. R., and Post, C. B. (2001) Molecular dynamics simulations of human rhinovirus and an antiviral compound, Biophys. J. 80, 121-129.
22. Grant, R. A., Hiremath, C. N., Filman, D. J., Syed, R., Andries, K., and Hogle, J. M. (1994) Structures of poliovirus complexes with antiviral drugs: implications for viral stability and drug design, Curr. Biol. 4, 784-797.
23. Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., Shaw, D. E., Francis, P., and Shenkin, P. S. (2004) Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy, J. Med. Chem. 47, 1739-1749.
24. Halgren, T. A., Murphy, R. B., Friesner, R. A., Beard, H. S., Frye, L. L., Pollard, W. T., and Banks, J. L. (2004) Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening, J. Med. Chem. 47, 1750-1759.
25. Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., Sanschagrin, P. C., and Mainz, D. T. (2006) Extra precision Glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes, J. Med. Chem. 49, 6177-6196.
26. Jorgensen, W. L., Maxwell, D. S., and Tirado-Rives, J. (1996) Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids, J. Am. Chem. Soc. 118, 11225-11236.
27. Mayer, M., and Meyer, B. (2001) Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor, J. Am. Chem. Soc. 123, 6108-6117.